Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 119 Pages
Report ld: 5523463
Request Sample
Customized Report
Automated Immunoassay Analyzer Market Size(US$)

CAGR 2026-2032
6.7%
Market Size,2032
USD 5,983
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automated Immunoassay Analyzer market was valued at US$ 3824 million in 2025 and is anticipated to reach US$ 5983 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Automated Immunoassay Analyzer competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.In 2025, global Automated Immunoassay Analyzer production reached approximately 136.6 K units and price is about 28 k USD/Unit.The average gross profit margin of this product is 55%.
Healthcare delivery is shifting from “detectable” to “accurate, fast, and consistently reliable.” Core drivers include the normalization of chronic disease and oncology management, regional lab collaboration under tiered healthcare, and hospitals’ rigid requirements for efficiency and quality governance. With mature methodologies, scalable menus, and strong compatibility with lab automation and digital workflows, automated immunoassay platforms remain central to capability upgrades and cost-structure optimization.Competition has moved beyond single-analyzer specs to end-to-end delivery: assay consistency and lot stability, reagent economics and supply resilience, installation quality and downtime control, and lifecycle compliance with software/change management all directly shape customer retention and long-term contract performance. Pricing pressure accelerates commoditization in routine assays, pushing suppliers to defend profitability through smarter menu architecture, differentiated clinical value, and superior service productivity.Demand is becoming “dual-centered.” Large hospitals and regional reference labs prioritize higher throughput, scalable expansion, and hands-off workflows; ED/ICU and selected outpatient settings emphasize shorter turnaround times, fewer manual steps, and stronger traceability. Procurement is also shifting from one-off CAPEX to an integrated evaluation of placement–reagent pull-through–service assurance, making reliable fulfillment, responsiveness, and digital operations capabilities increasingly decisive.Upstream value concentrates in three streams: biological essentials such as antibodies/antigens, magnetic particles, and luminescent substrates determine sensitivity, specificity, and consistency; consumables such as cuvettes, tips, tubing and seals drive contamination control and run cost; precision subsystems—liquid handling, thermal control, photo-detection, motion control and core electronics—define reliability and serviceability. The real differentiation is not a single component, but a replicable, auditable capability stack across supply chain, validation, and quality systems that scales sustainably.
This report delivers a comprehensive overview of the global Automated Immunoassay Analyzer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated Immunoassay Analyzer. The Automated Immunoassay Analyzer market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Automated Immunoassay Analyzer market comprehensively. Regional market sizes by Type, by Application, by Openness, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Automated Immunoassay Analyzer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Openness, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Automated Immunoassay Analyzer manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Automated Immunoassay Analyzer sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Automated Immunoassay Analyzer Market Overview
1.1 Product Definition
1.2 Automated Immunoassay Analyzer by Type
1.2.1 Global Automated Immunoassay Analyzer Market Value by Type: 2025 vs 2032
1.2.2 Benchtop Automated Immunoassay Analyzer
1.2.3 Floor-standing Automated Immunoassay Analyzer
1.3 Automated Immunoassay Analyzer by Openness
1.3.1 Global Automated Immunoassay Analyzer Market Value by Openness: 2025 vs 2032
1.3.2 Closed
1.3.3 Semi-open
1.3.4 Open
1.4 Automated Immunoassay Analyzer by End Users
1.4.1 Global Automated Immunoassay Analyzer Market Value by End Users: 2025 vs 2032
1.4.2 Hospital
1.4.3 Third-party Independent Laboratory
1.4.4 Other
1.5 Automated Immunoassay Analyzer by Application
1.5.1 Global Automated Immunoassay Analyzer Market Value by Application: 2025 vs 2032
1.5.2 Chemiluminescence Analysis
1.5.3 Fluorescent Immunoassay
1.5.4 Radioimmunoassay
1.5.5 Enzyme Immunoassay
1.5.6 Others
1.6 Global Automated Immunoassay Analyzer Market Size Estimates and Forecasts
1.6.1 Global Automated Immunoassay Analyzer Revenue 2021–2032
1.6.2 Global Automated Immunoassay Analyzer Sales 2021–2032
1.6.3 Global Automated Immunoassay Analyzer Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Automated Immunoassay Analyzer Market Competition by Manufacturers
2.1 Global Automated Immunoassay Analyzer Sales Market Share by Manufacturers (2021–2026)
2.2 Global Automated Immunoassay Analyzer Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Automated Immunoassay Analyzer Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Automated Immunoassay Analyzer, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Automated Immunoassay Analyzer, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Automated Immunoassay Analyzer, Product Types and Applications
2.7 Global Key Manufacturers of Automated Immunoassay Analyzer, Date of Entry into the Industry
2.8 Global Automated Immunoassay Analyzer Market Competitive Situation and Trends
2.8.1 Global Automated Immunoassay Analyzer Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Automated Immunoassay Analyzer Players Market Share by Revenue
2.8.3 Global Automated Immunoassay Analyzer Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Automated Immunoassay Analyzer Market Scenario by Region
3.1 Global Automated Immunoassay Analyzer Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Automated Immunoassay Analyzer Sales by Region: 2021–2032
3.2.1 Global Automated Immunoassay Analyzer Sales by Region: 2021–2026
3.2.2 Global Automated Immunoassay Analyzer Sales by Region: 2027–2032
3.3 Global Automated Immunoassay Analyzer Revenue by Region: 2021–2032
3.3.1 Global Automated Immunoassay Analyzer Revenue by Region: 2021–2026
3.3.2 Global Automated Immunoassay Analyzer Revenue by Region: 2027–2032
3.4 North America Automated Immunoassay Analyzer Market Facts & Figures by Country
3.4.1 North America Automated Immunoassay Analyzer Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Automated Immunoassay Analyzer Sales by Country (2021–2032)
3.4.3 North America Automated Immunoassay Analyzer Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Automated Immunoassay Analyzer Market Facts & Figures by Country
3.5.1 Europe Automated Immunoassay Analyzer Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Automated Immunoassay Analyzer Sales by Country (2021–2032)
3.5.3 Europe Automated Immunoassay Analyzer Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Immunoassay Analyzer Market Facts & Figures by Region
3.6.1 Asia Pacific Automated Immunoassay Analyzer Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Automated Immunoassay Analyzer Sales by Region (2021–2032)
3.6.3 Asia Pacific Automated Immunoassay Analyzer Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Automated Immunoassay Analyzer Market Facts & Figures by Country
3.7.1 Latin America Automated Immunoassay Analyzer Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Automated Immunoassay Analyzer Sales by Country (2021–2032)
3.7.3 Latin America Automated Immunoassay Analyzer Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Immunoassay Analyzer Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Immunoassay Analyzer Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Automated Immunoassay Analyzer Sales by Country (2021–2032)
3.8.3 Middle East and Africa Automated Immunoassay Analyzer Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Immunoassay Analyzer Sales by Type (2021–2032)
4.1.1 Global Automated Immunoassay Analyzer Sales by Type (2021–2026)
4.1.2 Global Automated Immunoassay Analyzer Sales by Type (2027–2032)
4.1.3 Global Automated Immunoassay Analyzer Sales Market Share by Type (2021–2032)
4.2 Global Automated Immunoassay Analyzer Revenue by Type (2021–2032)
4.2.1 Global Automated Immunoassay Analyzer Revenue by Type (2021–2026)
4.2.2 Global Automated Immunoassay Analyzer Revenue by Type (2027–2032)
4.2.3 Global Automated Immunoassay Analyzer Revenue Market Share by Type (2021–2032)
4.3 Global Automated Immunoassay Analyzer Price by Type (2021–2032)
5 Segment by Application
5.1 Global Automated Immunoassay Analyzer Sales by Application (2021–2032)
5.1.1 Global Automated Immunoassay Analyzer Sales by Application (2021–2026)
5.1.2 Global Automated Immunoassay Analyzer Sales by Application (2027–2032)
5.1.3 Global Automated Immunoassay Analyzer Sales Market Share by Application (2021–2032)
5.2 Global Automated Immunoassay Analyzer Revenue by Application (2021–2032)
5.2.1 Global Automated Immunoassay Analyzer Revenue by Application (2021–2026)
5.2.2 Global Automated Immunoassay Analyzer Revenue by Application (2027–2032)
5.2.3 Global Automated Immunoassay Analyzer Revenue Market Share by Application (2021–2032)
5.3 Global Automated Immunoassay Analyzer Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Diagnostics Automated Immunoassay Analyzer Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Automated Immunoassay Analyzer Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Company Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Danaher Automated Immunoassay Analyzer Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Company Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Siemens Healthcare Automated Immunoassay Analyzer Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 BioMerieux
6.5.1 BioMerieux Company Information
6.5.2 BioMerieux Description and Business Overview
6.5.3 BioMerieux Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BioMerieux Automated Immunoassay Analyzer Product Portfolio
6.5.5 BioMerieux Recent Developments/Updates
6.6 Ortho Clinical Diagnostics
6.6.1 Ortho Clinical Diagnostics Company Information
6.6.2 Ortho Clinical Diagnostics Description and Business Overview
6.6.3 Ortho Clinical Diagnostics Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ortho Clinical Diagnostics Automated Immunoassay Analyzer Product Portfolio
6.6.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.7 DiaSorin
6.7.1 DiaSorin Company Information
6.7.2 DiaSorin Description and Business Overview
6.7.3 DiaSorin Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 DiaSorin Automated Immunoassay Analyzer Product Portfolio
6.7.5 DiaSorin Recent Developments/Updates
6.8 Tosoh
6.8.1 Tosoh Company Information
6.8.2 Tosoh Description and Business Overview
6.8.3 Tosoh Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Tosoh Automated Immunoassay Analyzer Product Portfolio
6.8.5 Tosoh Recent Developments/Updates
6.9 Euroimmun
6.9.1 Euroimmun Company Information
6.9.2 Euroimmun Description and Business Overview
6.9.3 Euroimmun Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Euroimmun Automated Immunoassay Analyzer Product Portfolio
6.9.5 Euroimmun Recent Developments/Updates
6.10 Snibe
6.10.1 Snibe Company Information
6.10.2 Snibe Description and Business Overview
6.10.3 Snibe Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Snibe Automated Immunoassay Analyzer Product Portfolio
6.10.5 Snibe Recent Developments/Updates
6.11 Inova Diagnostics
6.11.1 Inova Diagnostics Company Information
6.11.2 Inova Diagnostics Description and Business Overview
6.11.3 Inova Diagnostics Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Inova Diagnostics Automated Immunoassay Analyzer Product Portfolio
6.11.5 Inova Diagnostics Recent Developments/Updates
6.12 Maccura Biotechnology
6.12.1 Maccura Biotechnology Company Information
6.12.2 Maccura Biotechnology Description and Business Overview
6.12.3 Maccura Biotechnology Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Maccura Biotechnology Automated Immunoassay Analyzer Product Portfolio
6.12.5 Maccura Biotechnology Recent Developments/Updates
6.13 Leadman Biochemistry
6.13.1 Leadman Biochemistry Company Information
6.13.2 Leadman Biochemistry Description and Business Overview
6.13.3 Leadman Biochemistry Automated Immunoassay Analyzer Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Leadman Biochemistry Automated Immunoassay Analyzer Product Portfolio
6.13.5 Leadman Biochemistry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Immunoassay Analyzer Industry Chain Analysis
7.2 Automated Immunoassay Analyzer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Immunoassay Analyzer Production Mode & Process Analysis
7.4 Automated Immunoassay Analyzer Sales and Marketing
7.4.1 Automated Immunoassay Analyzer Sales Channels
7.4.2 Automated Immunoassay Analyzer Distributors
7.5 Automated Immunoassay Analyzer Customer Analysis
8 Automated Immunoassay Analyzer Market Dynamics
8.1 Automated Immunoassay Analyzer Industry Trends
8.2 Automated Immunoassay Analyzer Market Drivers
8.3 Automated Immunoassay Analyzer Market Challenges
8.4 Automated Immunoassay Analyzer Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Automated Immunoassay Analyzer market size was US$ 3824 million in 2025 and is forecast to reach a readjusted size of US$ 5983 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 96
USD 4250.00
(Single User License)
The global market for Automated Immunoassay Analyzer was estimated to be worth US$ 3824 million in 2025 and is projected to reach US$ 5983 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 3950.00
(Single User License)
The global Automated Immunoassay Analyzer market size was US$ 3606 million in 2024 and is forecast to a readjusted size of US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 92
USD 4250.00
(Single User License)
The global Automated Immunoassay Analyzer market is projected to grow from US$ 3606 million in 2024 to US$ 5643 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 161
USD 4900.00
(Single User License)
In 2024, the global market size of Automated Immunoassay Analyzer was estimated to be worth US$ 3606 million and is forecast to reach approximately US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 158
USD 5900.00
(Single User License)
The global market for Automated Immunoassay Analyzer was estimated to be worth US$ 3606 million in 2024 and is forecast to a readjusted size of US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 119
USD 3950.00
(Single User License)
The global market for Automated Immunoassay Analyzer was valued at US$ 3606 million in the year 2024 and is projected to reach a revised size of US$ 5643 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published Date: 2024-04-17
Pages: 161
USD 5600.00
(Single User License)
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published Date: 2024-04-16
Pages: 152
USD 5900.00
(Single User License)
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published Date: 2024-04-07
Pages: 111
USD 4900.00
(Single User License)
The global Automated Immunoassay Analyzer market size was US$ 3824 million in 2025 and is forecast to reach a readjusted size of US$ 5983 million by 2032 with a CAGR of 6.7% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 96
The global market for Automated Immunoassay Analyzer was estimated to be worth US$ 3824 million in 2025 and is projected to reach US$ 5983 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global Automated Immunoassay Analyzer market size was US$ 3606 million in 2024 and is forecast to a readjusted size of US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 92
The global Automated Immunoassay Analyzer market is projected to grow from US$ 3606 million in 2024 to US$ 5643 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 161
In 2024, the global market size of Automated Immunoassay Analyzer was estimated to be worth US$ 3606 million and is forecast to reach approximately US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 158
The global market for Automated Immunoassay Analyzer was estimated to be worth US$ 3606 million in 2024 and is forecast to a readjusted size of US$ 5643 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 119
The global market for Automated Immunoassay Analyzer was valued at US$ 3606 million in the year 2024 and is projected to reach a revised size of US$ 5643 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-01-18
Pages: 88
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published: 2024-04-17
Pages: 161
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published: 2024-04-16
Pages: 152
An immunoassay analyzer is used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the samples.
Published: 2024-04-07
Pages: 111
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now